Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)
Annotations: Rat: (14) Mouse: (14) Human: (17) Chinchilla: (12) Bonobo: (14) Dog: (16) Squirrel: (12) Pig: (14)
Parent Terms Term With Siblings Child Terms
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest  
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator +   
negative regulation of DNA damage response, signal transduction by p53 class mediator +   
positive regulation of DNA damage checkpoint +   
positive regulation of DNA damage response, signal transduction by p53 class mediator +   
Any process that activates, maintains or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
positive regulation of DNA repair +   
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator +   
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage +   
positive regulation of telomere maintenance in response to DNA damage +  
regulation of DNA damage response, signal transduction by p53 class mediator +   
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator +   

Synonyms
Exact Synonyms: positive regulation of p53 induced by DNA damage response ;   up regulation of DNA damage response, signal transduction by p53 class mediator ;   upregulation of DNA damage response, signal transduction by p53 class mediator
Narrow Synonyms: activation of DNA damage response, signal transduction by p53 class mediator ;   stimulation of DNA damage response, signal transduction by p53 class mediator
Definition Sources: GOC:jl

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.